With the growing number of people with Alzheimer's disease, understanding their care is vital for doctors. Yet medical students often just learn the facts and may only see people with advanced disease who are at the hospital or nursing home. A study shows a new way to help medical students learn about the disease--at the art museum.
A natural protein fragment produced in the brain can act as an inhibitor of a key enzyme implicated in the onset of Alzheimer's disease, researchers have discovered for the first time. This is a finding that could lead to the development of new drugs to treat the disease, they say.
For the first time, UCLA researchers have shown that a natural protein fragment produced in the brain can act as an inhibitor of a key enzyme implicated in the onset of Alzheimer's disease, a finding that could lead to the development of new drugs to treat the disease.
Researchers are looking for biomarkers that might serve as an early warning system for Alzheimer's disease. The process is not without complications, but these scientists possess a collective “Rosie the Riveter” spirit.
At the University of Kentucky's Sanders-Brown Center on Aging, researchers are looking for biomarkers that might serve as an early warning system for AD. The process is not without complications, but these scientists possess a collective "Rosie the Riveter" spirit.
Diseases like Alzheimer's are caused when proteins aggregate and clump together. In a world first, scientists have successfully distinguished between the disease-causing aggregation forms of proteins. The finding can help change pharmaceutical treatment of neurodegenerative diseases.
Specific cardiovascular risk factors, such as alcohol consumption, smoking, obesity and diabetes, are associated with smaller regional brain volumes that may be early indicators of Alzheimer's disease and dementia according to a stu...
A strong association between insulin resistance and memory function decline has been found by researchers who suggest that this link increases the risk for Alzheimer's disease.
An Iowa State University study, published in the Journal of the American Medical Association Neurology, found a strong association between insulin resistance and memory function decline, increasing the risk for Alzheimer's disease.
Caregivers are often unaware that resources are available to provide comfort, and to help each person afflicted with Alzheimer's to end their life with dignity. Despite the efforts of researchers, Alzheimer's remains incurable. Researchers...Show More Summary
LOS ANGELES (AP) -- A judge has ruled that control of a landmark project on Alzheimer's disease belongs to the University of California, San Diego - handing the school a major victory in its lawsuit against the University of Southern California. Show More Summary
Those Netflix marathons may come at a price. Spoiler alert: too much television may lead to an increased risk of getting Alzheimer's disease. According to the Washington Post, researchers at the Northern California Institute for Research...Show More Summary
UC San Diego won a major legal battle Friday against USC when a judge ruled that control of a landmark project on Alzheimer's disease belongs to the La Jolla school.
Researchers announced this week that not only can regular aerobic exercise help protect the brain against Alzheimer’s, it can also positively impact those already diagnosed with the disease, due to increased blood flow to the brain’s memory and processing centers. What do you think?
Studies presented at the Alzheimer's Association International Conference suggest that physical exercise could both protect the brain and alleviate symptoms of Alzheimer's disease.
Scientists testing experimental drugs to prevent or reverse Alzheimer's disease have for years endured a drumbeat of inconclusive and disappointing trial results. But dementia researchers meeting in Washington, D.C., this week got some unexpectedly good news on the benefits of a therapy that is...
SLOWING IS GOOD. REVERSING IS BETTER. New antibody drugs show promise in slowing the advance of Alzheimer’s disease.
Results from three studies of aerobic exercise indicate that patients living Alzheimer’s disease, vascular dementia, and mild cognitive impairment (MCI) can benefit from working out. These studies indicate the aerobic exercise couldShow More Summary
Researchers say solanezumab, a drug that has been evaluated in a number of Phase III trials, may be effective for treating mild to moderate Alzheimer’s disease. If the drug is approved, it would be the first therapy available to patients...Show More Summary
Most studies so far have focused on the importance of physical activity before you develop Alzheimer’s. But can it treat the disease once you are diagnosed? Two studies hint that may be the case